All Her Favourite Fruit [Aardvarchaeology]
February 17th, 2008 Posted by: admin
![All Her Favourite Fruit [Aardvarchaeology]](http://medicalnewsweek.com/wp-content/uploads/2008/02/173807.jpg)
DARA BioSciences, Inc. and Point Therapeutics, Inc. Announce Consummation of Merger
February 16th, 2008 Posted by: admin
RALEIGH, N.C. and WELLESLEY HILLS, Mass., Feb. 12 /PRNewswire/ — DARA BioSciences, Inc. (”DARA”) and Point Therapeutics, Inc. (”Point”) announced the consummation of their merger transaction, effective as of the close of business on February 12, 2008, 2008.
Bookmark it:
Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year
February 16th, 2008 Posted by: admin
Reaffirms Outlook for Continued Growth
CAMBRIDGE, Mass., Feb. 13 /PRNewswire-FirstCall/ — Genzyme Corporation today reported financial results for the full year and fourth quarter of 2007 and provided an outlook for continued strong growth in 2008 and beyond.
Bookmark it:
Massachusetts Medical Society to raise awareness of men’s health issues
February 16th, 2008 Posted by: admin
Waltham, MA June 3, 2004–The Massachusetts Medical Society (MMS) announced today that the organization will expand beyond its role of simply raising awareness of the poor state of men’s health to one of identifying specific prevention and treatment strategies to improve men’s physical, psychological, and emotional health.
Bookmark it:
?The buzz in neighborhood nursing home care?
February 16th, 2008 Posted by: admin
OREM, UT September 23, 2004 — Beehive Homes a provider of elderly assisted living care in home sized facilities has been servicing Utah for the last 14 years. What started out as a care home for mom, has blossomed into more than 30 homes throughout Utah and over 100 homes throughout 16 states as far reaching as Indiana.
Bookmark it:
Post Traumatic Stress Is a Risk Factor for Chronic Disease
February 16th, 2008 Posted by: admin
(Ivanhoe Newswire) Veterans with Post Traumatic Stress Disorder (PTSD) are just as likely to have long term health problems as people with chronic disease risk factors like high white blood cell counts. However, very few healthcare providers screen PTSD patients for these biological markers.
Bookmark it:
Baxter’s Multiple-Dose Vial Heparin Linked to Severe Allergic Reactions
February 15th, 2008 Posted by: admin
FDA advises health care practitioners to switch suppliers and limit use of drug until problem identified
ROCKVILLE, Md., Feb. 11, 2008–The U.S. Food and Drug Administration announced today that Baxter Healthcare Corporation has temporarily stopped manufacturing multiple-dose vials of the injectable blood-thinning drug heparin due to reports of serious allergic reactions and hypotension (low blood pressure) in patients who receive high “bolus” doses of the drug.
Bookmark it: